Charles Virden, founder and CEO of VitalTE, and Lisa Stehno-Bittel, president and founder of Likarda, discuss a new approach to HRT delivery that would allow self-administration through infrequent injection.
Likarda
The new approach to HRT delivery
Charles Virden, founder and CEO of VitalTE, and Lisa Stehno-Bittel, president and founder of Likarda, discuss a new approach to HRT delivery that would allow self-administration through infrequent injection.
Published:
|
3 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.